Valeo Pharma Inc. — Form D

Valeo Pharma Inc. of KIRKLAND, A8, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-13. The offering totals $787K, of which $787K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Maureen C BreenanDirectorKIRKLAND, A8
Frederic J FasanoDirectorKIRKLAND, A8
Vincent P HogueDirectorKIRKLAND, A8
Richard J MackayDirectorKIRKLAND, A8
Steve J SaviukDirectorKIRKLAND, A8
Michel P TrudeauDirectorKIRKLAND, A8
Michael G WellsDirectorKIRKLAND, A8
Guy-Paul AllardExecutive OfficerKIRKLAND, A8
Michelle P BrienExecutive OfficerKIRKLAND, A8
Frederic J FasanoExecutive OfficerKIRKLAND, A8
Nelly P KomariExecutive OfficerKIRKLAND, A8
Richard J MackayExecutive OfficerKIRKLAND, A8
Luc P MainvilleExecutive OfficerKIRKLAND, A8
Helen P SaviukExecutive OfficerKIRKLAND, A8
Steve J SaviukExecutive OfficerKIRKLAND, A8
Jeff P SkinnerExecutive OfficerKIRKLAND, A8
Nathalie P TherrienExecutive OfficerKIRKLAND, A8

More